Available online 10 April 2024

Author links open overlay panelLia E. Bang MD, PhD 1, Jacob Kildevang Jensen MD, PhD 2, Lorenz Räber MD, PhD 3, Konstantinos C. Koskinas MD, MSc 3, Sarah Bär MD 3, Sylvain Losdat PhD 3, Christian M. Matter MD 4, Jacob Lonborg MD, PhD 1, Maria D. Radu Juul Jensen MD, PhD 1, Andreas Kjaer MD, DMSc 2, Thomas Engstrøm MD, PhD 1 4, Rasmus Sejersten Ripa MD, DMSc, FACC 1 5Show more

Funding: This substudy was funded by Copenhagen University Hospital – Rigshospitalet. The main PACMAN-AMI study was funded by Sanofi, Regeneron, and Infraredx.

Disclosures: Dr Räber has received institutional research grants from Abbott, Biotronik, Boston Scientific, HeartFlow, Infraredx, Swiss National Science Foundation, Swiss Heart Foundation, Sanofi, and Regeneron; and speaker/consultation fees from Abbott, Amgen, AstraZeneca, Canon, Novo Nordisk, Medtronic, Merck, Occlutech, Sanofi, and Vifor. Dr. Koskinas has received speaker fees by Amgen, Sanofi, and Daiichi Sankyo. Dr. Bär has received institutional research grants from Medis Medical Imaging Systems, Abbott, Bangerter-Rhyner Stiftung (Basel, Switzerland); and a personal research grant from the Swiss National Science Foundation, outside the submitted work. Dr. Matter has received research grants to the institution from the Swiss National Science Foundation, Swiss Heart Foundation, Swiss Academy of Medical Sciences, EliLilly, AstraZeneca, Roche, Amgen, Novartis, Novo Nordisk and MSD including speaker or consultant fees. Dr. Lonborg is on advisory board in Boston Scientific and speakers fee from Boston Scientific and Abbott. Dr. Juul Jensen is now a full time employee of Novo Nordisk. Dr. Engstrøm reports advidory board fee from Abbott, Novo Nordisk and speakers fee from Abbott. Dr. Ripa has received consultation fees from Novo Nordisk.

Clinical Trial Registration: ClinicalTrials.gov Identifier: NCT03067844

View full text

© 2024 Published by Elsevier on behalf of the American College of Cardiology Foundation.

Recommended articlesArticle Metrics